Immunology & Rheumatology Clinical Trials

Statistical methods in immunology & rheumatology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All immunology & rheumatology trials

1,062 results

• Common Safety Follow-up Trial of Tecemotide (L-BLP25): Complete Statistical AnalysisIndependent statistical analysis of Common Safety Follow-up Trial of Tecemotide (L-BLP25): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01423760).Phase NAResults postedn = 27NCT01423760
• Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS: Complete Statistical AnalysisIndependent statistical analysis of Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 360NCT00519636
• Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants: Complete Statistical AnalysisIndependent statistical analysis of Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01375205).Phase NAResults postedn = 100NCT01375205
• Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation: Complete Statistical AnalysisIndependent statistical analysis of Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation: primary endpoint results, effect estimate…Phase 1Results postedn = 9NCT07093008
• Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 118NCT02566902
• Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101): Complete Statistical AnalysisIndependent statistical analysis of Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 600NCT00075803
• Comparison of Outcomes in Mobile and Fixed-bearing Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Outcomes in Mobile and Fixed-bearing Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01027819).Phase 4Results postedn = 80NCT01027819
• Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid: Complete Statistical AnalysisIndependent statistical analysis of Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 4Results postedn = 150NCT00845195
• Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients: primary endpoint results, effect…Phase 1/2Results postedn = 18NCT03437577
• Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 251NCT03911401
• Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids: Complete Statistical AnalysisIndependent statistical analysis of Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids: primary endpoint…Phase 3Results postedn = 122NCT00658320
• CONCERTOComplete statistical analysis of the CONCERTO phase 3 trial of laquinimod in participants with relapsing remitting multiple sclerosis, including trial design, time-to-event methodology, the primary disease-progression result, safety, and statistical interpretation.Phase 3Results postedn = 2,199NCT01707992
• CONDA-YAPAIndependent statistical analysis of Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 16,660NCT01414413
• CONFIRMIndependent statistical analysis of the phase 3 CONFIRM trial of oral BG00012 with placebo and glatiramer acetate in relapsing-remitting multiple sclerosis, including trial design, annualized relapse rate methodology, safety, and statistical interpretation.Phase 3Results postedn = 1,417NCT00451451
• Connected Healthcare for Individuals Living at Home With Chronic Conditions: Complete Statistical AnalysisIndependent statistical analysis of Connected Healthcare for Individuals Living at Home With Chronic Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04339296).Phase NAResults postedn = 91NCT04339296
• CONSERVAIndependent statistical analysis of Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 3NCT05368402
• Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320069).Phase NAResults postedn = 25NCT04320069
• contRAst 2Complete statistical analysis of the phase 3 contRAst 2 trial of GSK3196165 (otilimab) versus placebo and tofacitinib in moderately to severely active rheumatoid arthritis.Phase 3Results postedn = 1,764NCT03970837
• Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): Complete Statistical AnalysisIndependent statistical analysis of Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 34NCT05422053
• Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03762473).Phase 2Results postedn = 89NCT03762473
• COVENANTIndependent statistical analysis of HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 535NCT03284866
• CPAP to Treat Cognitive Dysfunction in MS: Complete Statistical AnalysisIndependent statistical analysis of CPAP to Treat Cognitive Dysfunction in MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544373).Phase NAResults postedn = 135NCT02544373
• CPIT001Independent statistical analysis of Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1/2Results postedn = 46NCT02681302
• CRC027Independent statistical analysis of Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 21NCT01191190
• CREDO 2Complete statistical analysis of the phase 3 CREDO 2 trial evaluating two olokizumab dosing regimens versus placebo and adalimumab in patients with active rheumatoid arthritis receiving methotrexate.Phase 3Results postedn = 1,648NCT02760407
• CREDO 2Independent statistical analysis of Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate…Phase 3Results postedn = 1,648NCT02760407
• CRISTALLOIndependent statistical analysis of A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT…Phase 3Results postedn = 166NCT04285567
• Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 35NCT02100423
• CUTEXIndependent statistical analysis of Cold Urticaria Treatment With Xolair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580592).Phase 2Results postedn = 31NCT01580592
• Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 64NCT01057225
• Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 9NCT00949117
• DAHHS-2Independent statistical analysis of Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 80NCT02600325
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: Complete Statistical AnalysisIndependent statistical analysis of Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2/3Results postedn = 1,354NCT00080119
• DAISYIndependent statistical analysis of A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 103NCT06028438
• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 88NCT03871829
• DCCTIndependent statistical analysis of the Diabetes Control and Complications Trial (DCCT), covering its randomized parallel design, insulin behavioral intervention, statistical methodology, planned analysis, and interpretation of the ClinicalTrials.gov record.Phase NAn = 1,441NCT00360815
• Decision Making Tool for Firearm Storage: Complete Statistical AnalysisIndependent statistical analysis of Decision Making Tool for Firearm Storage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06382194).Phase NAResults postedn = 5NCT06382194
• DEFINEIndependent statistical analysis of DEFINE (NCT00420212), a phase 3 randomized, double-blind trial of oral BG00012 in relapsing-remitting multiple sclerosis, focusing on its 2-year time-to-event endpoint and statistical methodology.Phase 3Results postedn = 1,234NCT00420212
• Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1/2Results postedn = 11NCT03035331
• DEPICT 1Independent statistical analysis of Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268214).Phase 3Results postedn = 833NCT02268214
• Desensitization in Kidney Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Desensitization in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00908583).Phase 4Results postedn = 44NCT00908583
• DESTINATIONIndependent statistical analysis of the DESTINATION phase 3 trial of tezepelumab in adults and adolescents with severe, uncontrolled asthma, including trial design, registered endpoints, annualized asthma exacerbation rate results, safety, and statistical…Phase 3Results postedn = 951NCT03706079
• DESTINATIONIndependent statistical analysis of Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 951NCT03706079
• Detection of Graft Versus Host Disease With [18F]F-AraG: Complete Statistical AnalysisIndependent statistical analysis of Detection of Graft Versus Host Disease With [18F]F-AraG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367962).Phase 1Results postedn = 9NCT03367962
• Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate): Complete Statistical AnalysisIndependent statistical analysis of Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 57NCT04048382
• Developing an Activity Pacing Framework: Feasibility and Acceptability: Complete Statistical AnalysisIndependent statistical analysis of Developing an Activity Pacing Framework: Feasibility and Acceptability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03497585).Phase NAResults postedn = 112NCT03497585
• Developing and Testing a Comprehensive MS Spasticity Management Program: Complete Statistical AnalysisIndependent statistical analysis of Developing and Testing a Comprehensive MS Spasticity Management Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02170779).Phase 2Results postedn = 40NCT02170779
• DEVILIndependent statistical analysis of Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 37NCT00932828
• DFCI 10-106Independent statistical analysis of Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 729NCT01208662
• Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial: Complete Statistical AnalysisIndependent statistical analysis of Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03195140).Phase NAResults postedn = 103NCT03195140

← All therapeutic areas